1. Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation
- Author
-
Eva Santamaría, Arantza Azpilikueta, David Sancho, Saray Garasa, Iñaki Etxeberria, Alvaro Teijeira, Maria Angela Aznar, Michel Enamorado, Elixabet Bolaños, Ana Rouzaut, Ignacio Melero, Sara Labiano, Susana Inogés, Alfonso R. Sánchez-Paulete, imCORE Network, Ministerio de Ciencia y Competitividad (España), Unión Europea. Comisión Europea. 7 Programa Marco, Unión Europea. Comisión Europea. H2020, and Fundación BBVA
- Subjects
0301 basic medicine ,Agonist ,Cytotoxicity, Immunologic ,Cancer Research ,medicine.drug_class ,medicine.medical_treatment ,T-Lymphocytes ,Immunology ,Melanoma, Experimental ,Mitochondrion ,CD8-Positive T-Lymphocytes ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Lymphocytes, Tumor-Infiltrating ,Cancer immunotherapy ,Neoplasms ,medicine ,Tumor Microenvironment ,Animals ,Humans ,Gene Silencing ,RNA, Small Interfering ,Receptor ,Membrane Potential, Mitochondrial ,Mice, Knockout ,Chemistry ,CD137 ,Cell biology ,Mitochondria ,030104 developmental biology ,4-1BB Ligand ,mitochondrial fusion ,030220 oncology & carcinogenesis ,Cytokines ,Female ,Reprogramming ,CD8 ,Biomarkers - Abstract
T and NK lymphocytes express CD137 (4-1BB), a costimulatory receptor of the TNFR family whose function is exploitable for cancer immunotherapy. Mitochondria regulate the function and survival of T lymphocytes. Herein, we show that CD137 costimulation provided by agonist mAb and CD137L (4-1BBL) induced mitochondria enlargement that resulted in enhanced mitochondrial mass and transmembrane potential in human and mouse CD8+ T cells. Such mitochondrial changes increased T-cell respiratory capacities and were critically dependent on mitochondrial fusion protein OPA-1 expression. Mass and function of mitochondria in tumor-reactive CD8+ T cells from cancer-bearing mice were invigorated by agonist mAb to CD137, whereas mitochondrial baseline mass and function were depressed in CD137-deficient tumor reactive T cells. Tumor rejection induced by the synergistic combination of adoptive T-cell therapy and agonistic anti-CD137 was critically dependent on OPA-1 expression in transferred CD8+ T cells. Moreover, stimulation of CD137 with CD137 mAb in short-term cultures of human tumor-infiltrating lymphocytes led to mitochondria enlargement and increased transmembrane potential. Collectively, these data point to a critical link between mitochondrial morphology and function and enhanced antitumor effector activity upon CD137 costimulation of T cells. Cancer Immunol Res; 6(7); 798-811. ©2018 AACR. This project was supported by imCORE Network (Roche Genentech), MINECO (SAF2014-52361-R, 2017-83267-C2-1-R; I. Melero), European Commission VII Framework and Horizon 2020 programs (IACT and PROCROP), Fundacion de la Asociaci on Espa nola Contra el C ~ ancer (AECC), and Fundacion BBVA. A. Teijeira receives support from a Juan de la Cierva contract, MINECO. Electron and light microscopy CIMA services as well as Flow Cytometry CIMA facilities (Diego Alignani) and personnel at blood bank of Navarra are acknowledged for their technical support. We are also grateful to Drs. Lasarte and HervasStubbs for scientific discussion and to Dr. Paul Miller for editing the manuscript. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Sí
- Published
- 2017